GlucoTrack, Inc.
GCTKOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$16.1M | −$14.5M | −$7.1M | −$4.4M | −$4.0M | −$3.1M |
| Net income | −$19.4M | −$22.6M | −$7.1M | −$4.4M | −$4.1M | −$2.7M |
| Total assets | $7.8M | $5.9M | $4.9M | $2.4M | $6.3M | $10.6M |
| Total liabilities | $5.0M | $18.9M | $1.7M | $1.2M | $1.1M | $1.6M |
| Equity | $2.8M | −$13.0M | $3.2M | $1.2M | $5.2M | $9.0M |
| EPS (diluted) | $31.22 | $68.44 | $34.18 | $0.29 | $0.26 | $0.19 |
| Shares out. | 25.6M | 26.8M | 15.5M | 15.5M | 200.8M | 199.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −685.6%
- Return on assets
- −247.4%
- Return on capital (ROCE)
- −525.0%
- Liabilities / assets
- 63.9%
- Debt / equity
- 1.77×
- Book value / share
- $0.11
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -73.93distress
- Accruals / assets
- −52.9%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 1 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 17, 2021
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2021
- NT 10-Qmissed a reporting deadline ↗May 13, 2020
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2020
- NT 10-Kmissed a reporting deadline ↗Mar 29, 2019
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2014
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Armistice Capital, LlcPassive (13G)May 15, 2026
- Ikarian Capital, LlcPassive (13G)Feb 17, 2026
- Sabby Management, LlcPassive (13G)Jan 3, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Balo Andrew KDirector | Mar 25, 2025 | Grant | 75 | $0.00 |
| Malave LuisDirector | Mar 25, 2025 | Grant | 35 | $0.00 |
| Carter Erin CatherineDirector | Mar 25, 2025 | Grant | 32 | $0.00 |
| Goode PaulOfficer — Chief Executive Officer | Mar 25, 2025 | J | 42 | — |
| John A. Ballantyne Revocable Living Trust Dated 08/01/201710% owner | Nov 14, 2024 | J | 132,036 | $31.00 |
| Ballantyne JohnDirector | Nov 14, 2024 | J | 132,036 | $31.00 |
| Malave LuisDirector | Sep 30, 2021 | Grant | 8 | $0.00 |
| Carter Erin CatherineDirector | Dec 31, 2023 | Grant | 903 | $0.00 |
| Goode PaulOfficer — Chief Executive Officer | Nov 14, 2024 | Conversion | 796 | $31.20 |
| Danzig AllenDirector | Oct 4, 2022 | Grant | 44 | $0.00 |
| Balo Andrew KDirector | Mar 26, 2025 | Grant | 4,490 | $0.00 |
| Fischell RobertDirector | Aug 24, 2021 | Grant | 318 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 44,035 | 1.0 | -98.0% |
| Apr 30, 2026 | 2.2M | 1.0 | +223.2% |
| Apr 15, 2026 | 670,479 | 1.0 | -24.1% |
| Mar 31, 2026 | 883,209 | 1.0 | +1933.7% |
| Mar 13, 2026 | 43,428 | 1.0 | +53.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeMay 15, 2026
- Results of operationsMay 14, 2026
- Regulation FD disclosureMay 7, 2026
- Entered a material agreement · New financial obligation · Unregistered equity sale · Regulation FD disclosureApr 30, 2026
- Regulation FD disclosureApr 30, 2026
- Entered a material agreement · New financial obligation · Unregistered equity saleApr 14, 2026
- Results of operationsMar 30, 2026
- Regulation FD disclosureMar 27, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.